BeStock  
Stocks › Biotechnology › COGT

Cogent Biosciences COGT

US equityMarket cap rank #2102Biotechnology
$26.72 −$1.03 (-3.70%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.20 +1.82%
Open$27.26
Prev close$27.74
Day range$26.62 – $27.83
Volume2.13M
Market cap$4.65B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$117.18M-40.6% YoY
Net profit-$111.43M-37.7% YoY
Diluted EPS-$0.59-18.0% YoY
Free cash flow-$80.90M-25.7% YoY
Operating cash flow-$80.79M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-67.9MDec '24$-72.0MMar '25$-73.5MJun '25$-80.9MSep '25$-102.5MDec '25$-97.4MMar '26$-96.4MJun '26$-111.4MSep '26

Diluted EPS by quarter

-0.61Dec '24-0.52Mar '25-0.53Jun '25-0.50Sep '25-0.64Dec '25-0.53Mar '26-0.52Jun '26-0.59Sep '26

Free cash flow by quarter

$-60.7MDec '24$-67.1MMar '25$-54.7MJun '25$-64.4MSep '25$-79.9MDec '25$-87.3MMar '26$-77.6MJun '26$-80.9MSep '26

Annual revenue

$7.9MFY20$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-126.2%
Return on assets-64.8%
Return on invested capital-90.5%
Current ratio10.99
Liabilities / assets38.0%
Cash & investments$791.13M
Total debt$242.64M
Net cash (debt)$548.49M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $117.18M $102.64M $103.61M $333.36M $99.49M
Selling and Admin Expenses $42.09M $31.83M $28.24M $63.58M $23.93M
-General & Admin Expense $42.09M $31.83M $28.24M $63.58M $23.93M
Research & Development $75.10M $70.81M $75.37M $269.78M $75.56M
Operating Profit -$117.18M -$102.64M -$103.61M -$333.36M -$99.49M
Net Non-Operating Interest Income (Expense) $5.81M $6.24M $6.40M $11.63M $4.19M
Non-Operating Interest Income $7.05M $7.46M $7.61M $14.69M $5.48M
Non-Operating Interest Expense $1.24M $1.22M $1.21M $3.06M $1.29M
Other Income (Expense) -$51,000.00 -$11,000.00 -$140,000.00 -$7.20M -$7.19M
Other Non-Operating Income (Expenses) -$51,000.00 -$11,000.00 -$140,000.00 -$20,000.00 -$6,000.00
Pretax Profit -$111.43M -$96.41M -$97.35M -$328.94M -$102.49M
Net Profit -$111.43M -$96.41M -$97.35M -$328.94M -$102.49M
Profit from Continuing Operations -$111.43M -$96.41M -$97.35M -$328.94M -$102.49M
Net Income to Parent Company -$111.43M -$96.41M -$97.35M -$328.94M -$102.49M
Net Income to Common Stockholders -$111.43M -$96.41M -$97.35M -$328.94M -$102.49M
Basic EPS -$0.59 -$0.52 -$0.53 -$2.16 -$0.64
Diluted EPS -$0.59 -$0.52 -$0.53 -$2.16 -$0.64
Special Income (Charges) – – – -$7.18M –
-Less:Other Special Charges – – – $7.18M –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $832.14M $834.55M $903.01M $937.61M $937.61M
Total Current Assets $803.58M $804.82M $877.80M $910.36M $910.36M
Cash and Cash Equivalents & Short-Term Investments $791.13M $792.30M $866.38M $900.77M $900.77M
-Cash and Cash Equivalents $217.46M $181.17M $241.21M $312.01M $312.01M
-Short Term Investments $573.67M $611.13M $625.17M $588.75M $588.75M
Other Current Assets $12.45M $12.52M $11.43M $9.59M $9.59M
Total Non-Current Assets $28.56M $29.73M $25.20M $27.25M $27.25M
Net PPE $26.23M $27.37M $22.85M $23.54M $23.54M
-Gross PPE $26.23M $27.37M $22.85M $32.21M $32.21M
Other Non-Current Assets $2.33M $2.36M $2.36M $3.72M $3.72M
Total Liabilities $315.88M $302.16M $295.31M $301.24M $301.24M
Total Current Liabilities $73.12M $59.30M $57.98M $63.95M $63.95M
Payables $5.94M $7.49M $13.74M $9.50M $9.50M
-Accounts Payable $5.94M $7.49M $13.74M $9.50M $9.50M
Current Accrued Expenses $48.09M $36.50M $34.80M $30.42M $30.42M
Short-Term Debt and Capital Lease Obligation $1.58M $1.49M $1.38M $1.55M $1.55M
-Current Capital Lease Obligation $1.58M $1.49M $1.38M $1.55M $1.55M
Other Current Liabilities $2.34M $1.32M $1.85M $6.75M $6.75M
Total Non-Current Liabilities $242.77M $242.86M $237.33M $237.28M $237.28M
Long Term Debt and Capital Lease Obligation $242.64M $242.77M $237.27M $237.25M $237.25M
-Long Term Debt $223.74M $223.46M $223.17M $222.90M $222.90M
-Long Term Capital Lease Obligation $18.90M $19.32M $14.10M $14.36M $14.36M
Other Non-Current Liabilities $123,000.00 $90,000.00 $62,000.00 $33,000.00 $33,000.00
Total Equity $516.26M $532.39M $607.69M $636.37M $636.37M
Stockholders' Equity $516.26M $532.39M $607.69M $636.37M $636.37M
Capital Stock $64.93M $64.92M $64.92M $89.55M $89.55M
-Common Stock $174,000.00 $171,000.00 $171,000.00 $161,000.00 $161,000.00
-Preferred Stock $64.75M $64.75M $64.75M $89.39M $89.39M
Additional Paid-In Capital $1.95B $1.85B $1.83B $1.73B $1.73B
Retained Earnings -$1.49B -$1.38B -$1.29B -$1.19B -$1.19B
Gains/Losses Not Affecting Retained Earnings -$717,000.00 -$770,000.00 -$415,000.00 $355,000.00 $355,000.00
-Accumulated Depreciation – – – -$8.68M -$8.68M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$80.79M -$77.27M -$86.88M -$264.44M -$79.11M
Net cash flow from continuing operations -$80.79M -$77.27M -$86.88M -$264.44M -$79.11M
Net Income from Continuing Operations -$111.43M -$96.41M -$97.35M -$328.94M -$102.49M
Gain/Loss from Continuing Operations $0.00 -$1,000.00 $135,000.00 $7.18M –
Depreciation & Depletion & Amortization $1.25M $1.37M $1.16M $4.58M $1.14M
Other Non-Cash Items $287,000.00 $284,000.00 $278,000.00 $601,000.00 $238,000.00
Change in Working Capital $12.14M $1.34M -$6.83M $8.01M $132,000.00
-Change in Prepaid Assets -$1.32M $297,000.00 -$1.84M -$195,000.00 -$3.24M
-Change in Payables and Accrued Expense $13.73M $1.36M -$5.96M $8.18M $2.58M
-Change in Other Current Assets $26,000.00 $1,000.00 $1.36M $1.56M $1.19M
-Change in Other Current Liabilities -$295,000.00 -$323,000.00 -$393,000.00 -$1.53M -$394,000.00
Net cash flow from investing $37.31M $14.28M -$36.46M -$399.53M -$322.77M
Net Cash Flow from Continuing Investing Activities $37.31M $14.28M -$36.46M -$399.53M -$322.77M
Net PPE Purchase and Sale -$108,000.00 -$370,000.00 -$449,000.00 -$1.55M -$811,000.00
Net Investment Purchase and Sale $37.42M $14.65M -$36.01M -$397.97M -$321.96M
Financing Cash Flow $79.76M $2.96M $52.54M $878.23M $588.67M
Net Cash Flow from Continuing Financing Activities $79.76M $2.96M $52.54M $878.23M $588.67M
Net Issuance Payments Of Debt $0.00 – – $217.76M $168.47M
Net Common Stock Issuance $71.80M $0.00 $45.71M $159.32M -$80.72M
Proceeds from Stock Option Exercised $7.96M $2.96M $6.82M $552.67M $550.14M
Ending Cash Balance $217.88M $181.59M $241.62M $312.43M $312.43M
Net Change in Cash $36.29M -$60.04M -$70.80M $214.26M $186.80M
Beginning Cash Balance $181.59M $241.62M $312.43M $98.17M $125.63M
Free Cash Flow -$80.90M -$77.64M -$87.33M -$266.00M -$79.92M
Net Other Financing Charges – – – -$51.52M -$49.21M

Discussion

No comments yet — be the first to weigh in on COGT.

Sign in to join the discussion.

Scroll to Top